This panel will provide an overview of technology assessment (clinical/economic data analysis) conducted by private managed-care payers to determine coverage applicability. The panel will also explore how payer perception of value can be developed through clinical and health economic development efforts to support reimbursement for novel technology, including theranostics.



Objectives:

Understand payer perspective on technology assessment for novel diagnostics.

Understand payer utilization and category management for diagnostics in high-cost disease states.

Understand the "packaging" of manufacturer value to support payer coverage and reimbursement.